← SynDRA

GEMIFLOXACIN

SynDRA canonical compound SYN0000133 — structure-anchored drug synonym record

All known targets

• Bact gyrA; Bact gyrB
• Stap-coc parC
• gyrB
• parC

Mechanisms of action (all sources)

• DNA gyrase inhibitor
• Modulator
• parC INHIBITOR

Drug classes

• Anti-Bacterial Agents
• Anti-Infective Agents
• Antineoplastic Agents
• Enzyme Inhibitors
• Topoisomerase II Inhibitors
• Topoisomerase Inhibitors
• Quinolone Antimicrobial

ATC classes

• J01M · QUINOLONE ANTIBACTERIALS

Cross-references

• PubChem CID: 9571107
• ChEMBL: CHEMBL430
• DrugBank: DB01155
• ChEBI: CHEBI:101853
• KEGG: D02471
• RxNorm: 138099
• Wikipedia: Gemifloxacin
• TTD: D0VR7W

Synonyms

• gemifloxacin mesilate
• gemifloxacin mesylate
• Gemifloxacine
• Gemifloxacino
• Factiv
• Factive
• Gemifloxacin [INN]
• Gemifloxacin mesilate
• LB-20304
• LB 20304a
• SB-265805
• Factiv (TN)
• Factive (TN)
• Gemifloxacin (INN)
• 7-(3-Aminomethyl)-4-methoxyimino-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
• 7-(3-Aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
• 7-[3-(aminomethyl)-4-(methoxyimino)pyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
• OKR68Y0E4T
• LB 20304
• CHEBI:101853
• LB20304
• Gemifloxacinum
• RefChem:56635
• DTXCID9028469
• J01MA15
• SB265805
• Gemifioxacin
• Gemifloxacin (mesylate)
• UNII-OKR68Y0E4T
• SR-05000001958
• C18H20FN5O4
• HSDB 8027
• SB-265805S;LB-20304a
• GEMIFLOXACIN [MI]
• GEMIFLOXACIN [VANDF]
• BSPBio_002308
• GEMIFLOXACIN [WHO-DD]
• SCHEMBL136633

Reported adverse events

• Tendinitis
• Peripheral neuropathy
• Rash